A controlled study of the effect of orphenadrine hydrochloride (Disipal) on vertigo in patients with spontaneous vestibular disease.
D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D006801:Humans; D007759:Labyrinth Diseases / Q000150:complications; D009966:Orphenadrine / Q000627:therapeutic use*; D014717:Vertigo / Q000188:drug therapy*; D014722:Vestibule, Labyrinth
D009966:Orphenadrine